Cryo-Save Group N.V.: positive outcome for Cryo-Save in legal proceedings against Salveo: EGM 9 September 2013 postponed

September 6, 2013 Group News
Tags

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces that the extraordinary general meeting of shareholders (“EGM”) scheduled for 9 September 2013, that was convened by the company’s minority shareholder Salveo Holding S.A. (“Salveo”) in breach of the 180-day response time that Cryo-Save’s board of directors invoked, has been adjourned by court order.

read more

Salveo breaches response time and convenes EGM

July 26, 2013 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces today that it has taken notice of the fact that Salveo Holding S.A. (‘Salveo’), the company’s minority shareholder with 27%, has convened an extraordinary general meeting of shareholders (‘EGM’) that shall be proposed to resolve on the appointment of a new executive director (CEO) and the replacement of one non-executive director.

read more

Cryo-Save Group N.V. – Board change

June 25, 2013 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces today that Mr Johan Goossens decided to step back from office as a Non-Executive Board Member with immediate effect.

read more

Presentation of proposition and invocation response time

June 3, 2013 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces today that it has been presented with the outlines of the proposition of Salveo Holding S.A (‘Salveo’), the company’s major shareholder, underlying its request to convene an extraordinary general meeting of shareholders (‘EGM’) that shall be proposed to resolve on the appointment of a new CEO and the replacement of one non-executive director.

read more

Ms. Evi Mattil, CCO, will to take over the CEO functions ad interim

May 31, 2013 Group News
Tags
,

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces today that following on Mr. Arnoud van Tulder’s retirement as Chief Executive Officer, effective June 1, 2013, Ms. Evi Mattil, Chief Commercial Officer, will to take over with immediate effect and on an ad interim basis the functions of Arnoud van Tulder. The search and formal procedure for the nomination of a new CEO will be started immediately.

Resignation Mr. Arnoud van Tulder as CEO

May 30, 2013 Group News
Tags

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces today that Mr. Arnoud van Tulder will for personal reasons retire as Chief Executive Officer, effective June 1, 2013.

read more

Update of Matters Salveo

May 30, 2013 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces further to its press release dated 15 May and as a matter of update of matters regarding Salveo Holding S.A. (‘Salveo’), Cryo-Save’s new 27 % shareholder, that it has received a request by Salveo to convene an extraordinary general meeting of shareholders.

read more

Board change

May 23, 2013 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Company’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces that the Board of Directors has decided to appoint its Non-Executive Director Mr. Walter van Pottelberge as Chairman of the Board as of today. Mr. Van Pottelberge will replace Mr. Johan Goossens, who will remain a NonExecutive Director.